HuGE Literature Finder
Records
1
-
14
| Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 May . Delabio Auer Eduardo, van Tong Hoang, Maldaner Amorim Leonardo, Malheiros Danielle, Hoan Nghiem Xuan, Issler Hellen Caroline, Petzl-Erler Maria Luiza, Holsbach Beltrame Márcia, Beate Winter Boldt Angelica, Toan Nguyen Linh, Song Le Huu, Velavan Thirumalaisamy P, Augusto Danillo |
| [Distribution of KIR/HLA alleles among ethnic Han Chinese patients with hepatocellular carcinoma from southern China]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 May 36 (5): 439-442. Gao Suqing, Jiao Baihai, Hong Wenxu, Cai Chuangchuang, Zhong Yanping, Quan Zhanrou, Chen Hao, Xu Yunpi |
| The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways. Tissue antigens 2015 Oct 86 (4): 267-75. Hydes T J, Moesker B, Traherne J A, Ashraf S, Alexander G J, Dimitrov B D, Woelk C H, Trowsdale J, Khakoo S |
| Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort. Medical science monitor : international medical journal of experimental and clinical research 2014 20 28-34. Kibar Filiz, Goruroglu Ozturk Ozlem, Ulu Asl?han, Erken Eren, Inal Seza, Dinkci Suzan, Kurtaran Behice, Tasova Yesim, Aksu Hasan Salih Zeki, Yaman Akg |
| Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil. Genetics and molecular biology 2013 Mar 36 (1): 22-7. de Vasconcelos Janaina Mota, de Jesus Maués Pereira Móia Lizomar, Amaral Ivanete do Socorro Abraçado, Miranda Esther Castello Branco Mello, Cicalisetakeshita Louise Yukari, de Oliveira Layanna Freitas, de Araújo Melo Mendes Lilian, Sastre Danuta, Tamegão-Lopes Bruna Pedroso, de Aquino Pedroza Larysse Santa Rosa, Batista Dos Santos Sidney Emanuel, Soares Manoel do Carmo Pereira, de Araújo Marialva Tereza Ferreira, Bandeira Camila Lucas, de Sousa da Silva Adriana Maria Paixão, de Medeiros Zilene Lameira, Sena Leonardo, Demachki Samia, Dos Santos Eduardo José Me |
| KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan. PloS one 2013 8 (12): e83381. Nozawa Yuichi, Umemura Takeji, Joshita Satoru, Katsuyama Yoshihiko, Shibata Soichiro, Kimura Takefumi, Morita Susumu, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
| IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS medicine 2011 Sep 8 (9): e1001092. Suppiah Vijayaprakash, Gaudieri Silvana, Armstrong Nicola J, O'Connor Kate S, Berg Thomas, Weltman Martin, Abate Maria Lorena, Spengler Ulrich, Bassendine Margaret, Dore Gregory J, Irving William L, Powell Elizabeth, Hellard Margaret, Riordan Stephen, Matthews Gail, Sheridan David, Nattermann Jacob, Smedile Antonina, Müller Tobias, Hammond Emma, Dunn David, Negro Francesco, Bochud Pierre-Yves, Mallal Simon, Ahlenstiel Golo, Stewart Graeme J, George Jacob, Booth David R, |
| A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology 2011 Jul 141 (1): 320-5, 325.e1-2. Knapp Susanne, Warshow Usama, Ho K M Alexander, Hegazy Doha, Little Ann-Margaret, Fowell Andrew, Alexander Graeme, Thursz Mark, Cramp Matthew, Khakoo Salim |
| Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B. Clinical immunology (Orlando, Fla.) 2010 Oct 137 (1): 139-46. Gao Xuejun, Jiao Yulian, Wang Laicheng, Liu Xiaowen, Sun Wenping, Cui Bin, Chen Zijiang, Zhao Yuer |
| Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (Baltimore, Md.) 2010 Apr 51 (4): 1168-75. Knapp Susanne, Warshow Usama, Hegazy Doha, Brackenbury Louise, Guha I Neil, Fowell Andrew, Little Ann-Margaret, Alexander Graeme J, Rosenberg William M C, Cramp Matthew E, Khakoo Salim |
| Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. Journal of virology 2010 Jan 84 (1): 475-81. Vidal-Castiñeira J R, López-Vázquez A, Díaz-Peña R, Alonso-Arias R, Martínez-Borra J, Pérez R, Fernández-Suárez J, Melón S, Prieto J, Rodrigo L, López-Larrea |
| Protective KIR-HLA interactions for HCV infection in intravenous drug users. Molecular immunology 2009 Aug 46 (13): 2723-7. Zúñiga Joaquín, Romero Viviana, Azocar José, Terreros Daniel, Vargas-Rojas María Inés, Torres-García Diana, Jiménez-Alvarez Luis, Vargas-Alarcón Gilberto, Granados-Montiel Julio, Husain Zaheed, Chung Raymond T, Alper Chester A, Yunis Edmond |
| Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Apr 15 (4): 4. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F |
| HLA-C and KIR genes in hepatitis C virus infection. Human immunology 2005 Nov 66 (11): 1106-9. Montes-Cano Marco Antonio, Caro-Oleas José Luis, Romero-Gómez Manuel, Diago Moisés, Andrade Raul, Carmona Isabel, Aguilar Reina José, Núñez-Roldán Antonio, González-Escribano María Francis |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: